Research Topics
Species | Jaime DavidsonSummaryAffiliation: Endocrine and Diabetes Associates of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to actionJaime A Davidson
University of Texas Southwestern Medical School, Dallas, TX, USA
J Cardiometab Syndr 2:238-43. 2007..A combined effort of health-influencing and health-governing bodies is needed on all levels to address the CVD problem in the Latino/Hispanic population...
Case study: lessons learned in the care of a 63-year-old woman with type 2 diabetesJaime A Davidson
Endocrinologist Endocrine and Diabetes Associates of Texas and Medical City Dallas Hospital, Texas 75230, USA
Clin Cornerstone 7:S18-24. 2005..A case study of a 63-year-old woman with type 2 DM offers important lessons learned in diabetes management...
How the diabetic eye loses visionJaime A Davidson
Division of Endocrinology, University of Texas, Southwestern Medical School, Dallas, Texas 75230, USA
Endocrine 32:107-16. 2007..Many experts and associations recommend that patients with diabetes have an yearly, thorough, dilated eye exam. This manuscript describes the case history of a patient with diabetes and vision loss...
New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's viewJaime A Davidson
Endocrine and Diabetes Associates of Texas, Dallas, Texas 75230, USA
Diabetes Care 27:805-12. 2004
Avoiding the looming Latino/Hispanic cardiovascular health crisis: a call to actionJaime A Davidson
University of Texas Southwestern Medical School, Dallas, TX, USA
Ethn Dis 17:568-73. 2007..It is therefore imperative to understand this population's risk of CVD and the most effective and culturally sensitive treatment methods...
Biphasic insulin aspart 30: literature review of adverse events associated with treatmentJaime Davidson
Endocrine and Diabetes Associates of Texas, Dallas, TX 75230, USA
Clin Ther 27:S75-88. 2005..It provides overall glycemic control similar to biphasic human insulin 30 (BHI 30, 30% human insulin and 70% neutral protamine Hagedorn [NPH] insulin) in patients with type 1 or type 2 diabetes...
Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized studyJ A Davidson
Endocrine and Diabetes Associates of Texas, Dallas, TX 75230, USA
Diabetes Obes Metab 8:164-74. 2006..To determine the effects of pioglitazone treatment combined with insulin on glucose and lipid metabolism in patients with type 2 diabetes...
Strategies for improving glycemic control: effective use of glucose monitoringJaime Davidson
University of Texas Southwestern Medical School, Endocrine and Diabetes Associates of Texas, Dallas, Texas 75230, USA
Am J Med 118:27S-32S. 2005..SMBG should include postprandial monitoring to identify glycemic excursions after meals, to indicate the need for lifestyle adjustments, and to provide patient feedback on dietary choices...
A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patientsJaime Davidson
University of Texas Southwestern Medical School, Dallas, Texas, USA
Clin Ther 30:287-93. 2008....
Barriers to achieving optimal glycemic control in a multi-ethnic society: a US focusSamuel Dagogo-Jack
Division of Endocrinology, Diabetes and Metabolism, University of Tennessee College of Medicine, Memphis, Tennessee 38163, USA
Curr Diabetes Rev 2:285-93. 2006..Addressing these issues may help to decrease the ethnic disparities that currently exist in diabetes care...
Should postprandial glucose be measured and treated to a particular target? YesJaime Davidson
UTSWMS, Endocrine and Diabetes Association of Texas, Dallas, Texas 75230, USA
Diabetes Care 26:1919-21. 2003
New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003Jaime Davidson
Endocrine and Diabetes Association of Texas, Dallas, TX, USA
Transplantation 75:SS3-24. 2003
A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes Jaime A Davidson
Department of Medicine, University of Texas, Southwestern Medical School, Dallas, Texas 75248, USA
Clin Ther 29:1900-14. 2007....
Insulin resistance syndrome: implications for the Latino/Hispanic populationJaime A Davidson
Endocr Pract 9:26-7. 2003
Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitusJaime A Davidson
University of Texas Southwestern Medical School, Dallas, Texas, USA
Drug Saf 27:1205-16. 2004..The lower doses of metformin and glibenclamide with the combination tablet approach, and the design of the combination tablets themselves, may underlie the beneficial tolerability profile of this treatment...
Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task ForcePaul S Jellinger
Endocr Pract 13:260-8. 2007
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et Paul S Jellinger
Diabetes Care 30:e16-7; author reply e18-20, e21-2. 2007
Cardiovascular disease prevention and care in Latino and Hispanic subjectsJaime A Davidson
University of Texas Southwestern Medical School, Dallas, Texas, USA
Endocr Pract 13:77-85. 2007..To determine the scope, impact, and health care limitations relative to cardiovascular disease (CVD) in the Latino-Hispanic population...
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesChristopher G Parkin
Diabetes Care 30:192-3; author reply 194-6. 2007
Introductory remarks: diabetes care in America - "a sense of urgency"Jaime A Davidson
University of Texas Southwestern Medical Center, Dallas, USA
Endocr Pract 12:13-5. 2006..CONCLUSION: Substantial clinical and financial benefits can be gained through better control of diabetes. Finding ways to meet this challenge must be a priority...
ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendationsHarold E Lebovitz
Endocr Pract 12:6-12. 2006
Treatment of the patient with diabetes: importance of maintaining target HbA(1c) levelsJaime A Davidson
Endocrine and Diabetes Associates of Texas, Dallas, TX 75230, USA
Curr Med Res Opin 20:1919-27. 2004..To review clinical trial evidence supporting treatment of patients to a near-normal HbA(1c) target level and outline therapeutic strategies that optimize glycemic control...
Comment: insulin strategies for type 2 diabetes mellitusJaime A Davidson
Ann Pharmacother 39:975-6; author reply 976. 2005
Postprandial glucose regulation: new data and new implicationsLawrence A Leiter
St Michael s Hospital, University of Toronto, Toronto, Canada
Clin Ther 27:S42-56. 2005..However, physicians continue to rely on fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) to guide management...
Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetesJohn B Buse
University of North Carolina School of Medicine, Chapel Hill, 27599, USA
Clin Ther 27:1181-95. 2005..Peroxisome proliferator-activated receptors (PPARs) present a therapeutic target, and simultaneous activation of PPAR-alpha and PPAR-gamma may provide improvements in glycemic control and dyslipidemia in patients with type 2 diabetes...
